Todd Wider
CIK 1642715 · last filed 2026-07-01
Todd Wider is a corporate insider who has filed 33 SEC Form 4 insider transactions across 6 companies since 2015. The most recent filing, for ASPI, was dated Sep 25, 2026. Across all open-market trades the lifetime net is −$2.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ABEO price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
DALLAS, TX 75219
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ASPI | Director | 722,247 | $2.10 | $1.52M | -$1.18M | 8 | 2026-07-01 |
| ARYA Sciences Acquisition Corp IV (ARYD) Delisted | Director | — | $6.64 | — | $0 | 1 | 2024-07-31 |
| ABEO | Director | 16,907 | $4.59 | $77.6K | -$1.54M | 12 | 2022-09-28 |
| ABEONA THERAPEUTICS INC. (ABEOW) Delisted | Director | 100,000 | — | — | $0 | 4 | 2019-05-23 |
| ABEONA THERAPEUTICS INC. (ABEO.W) Delisted | Director | 75,000 | — | — | $137.4K | 3 | 2016-09-28 |
| ABEONA THERAPEUTICS INC. (PTBI.W) Delisted | Director | 50,000 | — | — | $0 | 1 | 2015-06-19 |
Recent Filings
33 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-09-25 | ASPI | Notice (144) | −200,000 | -$590.0K | EDGAR |
| 2026-07-01 | ASPI | Sell (S) | −100,000 | -$618.5K | EDGAR |
| 2026-06-29 | ASPI | Notice (144) | −100,000 | -$628.0K | EDGAR |
| 2025-12-22 | ASPI | Grant (A) | +36,548 | $0 | EDGAR |
| 2025-11-14 | ASPI | Grant (A) | +25,469 | $0 | EDGAR |
| 2025-10-03 | ASPI | Mixed | — | -$648.8K | EDGAR |
| 2025-09-12 | ASPI | Notice (144) | −75,000 | -$657.8K | EDGAR |
| 2024-11-21 | ASPI | Grant (A) | +42,522 | $0 | EDGAR |
| 2024-08-14 | ASPI | Grant (A) | +172,864 | $0 | EDGAR |
| 2024-07-31 | ARYA Sciences Acquisition Corp IV (ARYD) Delisted | Disp (D) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.